Understanding the functions of endogenous and exogenous tissue-type plasminogen activator during stroke

Stroke. 2015 Jan;46(1):314-20. doi: 10.1161/STROKEAHA.114.006698. Epub 2014 Nov 13.

¹ From the INSERM UMR-S U919 Serine Proteases and Pathophysiology of the Neurovascular Unit, Université Caen Basse Normandie, GIP Cyceron, Caen, France (F.D., J.P., C.A., D.V.); and Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium (R.L.).
² From the INSERM UMR-S U919 Serine Proteases and Pathophysiology of the Neurovascular Unit, Université Caen Basse Normandie, GIP Cyceron, Caen, France (F.D., J.P., C.A., D.V.); and Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium (R.L.). [email protected].

No abstract available

Keywords: stroke; thrombolytic therapy; tissue-type plasminogen activator.

Publication types